当前位置: 首页 > 期刊 > 《风湿病与关节炎》 > 2022年第5期
编号:585298
撤热存津颗粒治疗原发性干燥综合征的临床疗效及对外周血Th17/Treg细胞免疫平衡的影响
http://www.100md.com 2022年5月30日 风湿病与关节炎 2022年第5期
     楼蒙妮 李延萍 吴斌

    【摘 要】目的:研究撤熱存津颗粒治疗原发性干燥综合征(pSS)的临床疗效及对外周血Th17/Treg细胞免疫平衡的影响。方法:选取阴虚燥热证pSS患者27例为pSS组,20例健康志愿者为对照组,对入组的pSS患者予口服撤热存津颗粒治疗,3个月为1个疗程,比较治疗前后中医证候评分、欧洲抗风湿病联盟干燥综合征患者报告指数(ESSPRI)评分、腺体功能SchirmerⅠ试验、唾液流率、红细胞沉降率、C反应蛋白、免疫球蛋白的变化,外周血Th17细胞和Treg细胞占CD4+T细胞的比例、Th17/Treg及IL-6、IL-17A的浓度差异。结果:入组时pSS组的IL-6、IL-17A、Th17、Th17/Treg均高于对照组(P 0.05)。pSS组患者治疗后中医证候评分、ESSPRI评分较治疗前明显下降(P 0.05);20例pSS患者治疗达到有效,治疗后IL-6、IL-17A、Th17、Th17/Treg较治疗前明显下降(P +T细胞;免疫平衡

    Clinical Efficacy of Chere Cunjin Keli(撤热存津颗粒)in the Treatment of Primary Sj?gren's Syndrome and Its Effect on the Immune Balance of Peripheral Blood Cells Th17/Treg

    LOU Meng-ni,LI Yan-ping,WU Bin

    【ABSTRACT】Objective:To study the clinical efficacy of Chere Cunjin Keli(撤热存津颗粒)in the treatment of primary Sj?gren's syndrome(pSS)and its effect on the immune balance of peripheral blood cells Th17/Treg.Methods:Twenty-seven patients with pSS of yin deficiency and dryness heat syndrome were selected as the pSS group and 20 healthy volunteers as the healthy control group.The patients with pSS were treated with Chere Cunjin Keli for 3 months.The changes of TCM syndrome score ......

您现在查看是摘要页,全文长 11140 字符